AMEA
First Liquid Biopsy Approved by US FDA for comprehensive tumor mutation profiling across all solid cancers and approved by Japan MHLW.
CRC, colorectal cancer; MHLW, Ministry of Health, Labour, and Welfare; NSCLC, non-small cell lung cancer.
Many more in development
